Nanosonics Limited (AU:NAN) has released an update.
Nanosonics Limited reports a resilient financial performance for 2024, with a 7% increase in its global installed base and a 2% rise in sales revenue to $170 million, overcoming initial challenges to end the year on a strong note. The company’s strategic shift and product upgrades, particularly in North America, have set a robust platform for future growth, underscored by a substantial increase in free cash flow and a promising pipeline in infection prevention.
For further insights into AU:NAN stock, check out TipRanks’ Stock Analysis page.
